-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TK-90 in Chemotherapy Induced Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TK-90 in Chemotherapy Induced Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TK-90 in Chemotherapy Induced Oral Mucositis Drug Details: TK-90 (TK-112690)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TK-8001 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TK-8001 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TK-8001 in Solid Tumor Drug Details: TK-8001 (T-1367) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TK-001 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TK-001 in Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TK-001 in Breast Cancer Drug Details: TK-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aglatimagene Besadenovec in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aglatimagene Besadenovec in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aglatimagene Besadenovec in Prostate Cancer Drug Details: aglatimagene besadenovec is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aglatimagene Besadenovec in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aglatimagene Besadenovec in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aglatimagene Besadenovec in Pancreatic Ductal Adenocarcinoma Drug Details: aglatimagene besadenovec...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aglatimagene Besadenovec in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aglatimagene Besadenovec in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aglatimagene Besadenovec in High-Grade Glioma Drug Details: aglatimagene besadenovec is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aglatimagene Besadenovec in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aglatimagene Besadenovec in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aglatimagene Besadenovec in Non-Small Cell Lung Cancer Drug Details:...
-
Sector Analysis
NewUnited Kingdom (UK) Womenswear Market Size and Trend Analysis by Category, Segments, Region, Key Brands, and Forecast to 2028
United Kingdom (UK) Womenswear Market Report Overview The UK womenswear market size was estimated to be £24.8 billion in 2023. The market will witness steady growth at a CAGR of more than 1% during 2023-2028 due to long-term economic improvement. United Kingdom (UK) Womenswear Market Outlook 2023-2028 (£ Billion) Buy the Full Report for More Insights into the UK Womenswear Market, Download a Free Report Sample The UK womenswear market research report offers comprehensive insightsinto the womenswear market in the UK...
-
Sector Analysis
NewUnited Kingdom (UK) Mother’s Day Market Analysis, Trends, Consumer Attitudes and Buying Dynamics, 2024 Update
The UK Mother's Day 2024 report forms part of GlobalData's Retail Occasions series, and offers a comprehensive insight into the consumer dynamics and spending habits of UK consumers for Mother's Day. The report analyses the major players, the main trends, and consumer attitudes. The proportion of UK consumers that participated in Mother’s Day has increased this year, but those spending on the event fell. This has largely been driven by consumers choosing to spend time with their families rather than...
-
Sector Analysis
United Kingdom (UK) Accessories Market Analysis, Trends, Consumer Preferences and Forecast to 2027
United Kingdom (UK) Accessories Market Report Overview The United Kingdom (UK) accessories market size was £5.9 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2027. Even though inflationary pressures led consumers to cut back on fashion spend due to higher prices and less discretionary income, the high presence of luxury goods within the fashion sector allowed accessories to achieve slightly stronger growth than clothing and footwear. UK Accessories Market Outlook, 2023-2027...